FDA Adds 37 Chinese Food Packaging Firms to Import Alert

On May 14, 2026, the U.S. Food and Drug Administration (FDA) updated Import Alert 99-08, adding 37 Chinese manufacturers of food contact materials and packaging to its automatic detention list. The action stems from noncompliance with the Federal Food, Drug, and Cosmetic Act as amended by the Food Safety Modernization Act (FSMA), specifically Section 117’s requirement for a Qualified Supplier Attestation (QSA). This development directly affects exporters, importers, brand owners, and logistics providers engaged in U.S.-bound food packaging supply chains.

Event Overview

On May 14, 2026, the FDA issued an update to Import Alert 99-08 (“Detention Without Physical Examination of Food Contact Substances Due to Lack of FSMA Compliance”). Thirty-seven Chinese enterprises producing aluminum foil laminated bags, vacuum-metallized paper, and PET-based heat-seal lidding materials were added to the alert. The stated basis is failure to submit or maintain a valid Qualified Supplier Attestation under FSMA Rule 117. Under this rule, foreign suppliers must affirm their compliance with preventive controls for food contact substances — a declaration that must be submitted via the FDA’s Supplier Verification Program portal and kept current. No enforcement discretion or grace period applies to firms newly listed.

Industries Affected

Direct trading enterprises: U.S.-based importers and distributors sourcing finished food packaging from China now face heightened risk of shipment rejection. Automatic detention triggers mandatory reconditioning, re-export, or destruction unless the supplier provides verifiable QSA documentation within 10 working days — a timeline often incompatible with standard air/ocean transit windows. Financial exposure includes demurrage, storage fees, and contractual penalties with downstream food brand clients.

Raw material procurement enterprises: Companies procuring base substrates (e.g., PET film, metallized paper rolls, aluminum foil) from Chinese converters are indirectly exposed. While raw material producers themselves may not require QSA, their downstream converters — who transform those inputs into regulated food contact articles — do. Procurement teams must now map tier-two supplier compliance status, not just first-tier contracts, to avoid cascading liability.

Processing and manufacturing enterprises: Chinese packaging converters exporting to U.S. food brands must now treat QSA submission as a prerequisite for order acceptance — not a post-shipment administrative step. Failure to do so disrupts production scheduling, increases lead times, and undermines competitiveness against ASEAN or Mexican suppliers already integrated into FDA’s Voluntary Qualified Importer Program (VQIP).

Supply chain service enterprises: Third-party logistics providers, customs brokers, and regulatory consultants handling FDA entry filings must now validate QSA status before release authorization. A growing number of brokers report increased pre-clearance verification requests from U.S. Customs and Border Protection (CBP), citing alignment with FDA’s updated Import Alert guidance. Service-level agreements increasingly include clauses assigning liability for FSMA-related detention costs to the importer of record.

Key Focus Areas and Recommended Actions

Verify supplier eligibility on FDA’s public ‘Green List’

As of May 14, 2026, FDA maintains a publicly accessible list of firms with active, validated QSAs — distinct from the Import Alert database. Enterprises should cross-check all Chinese packaging suppliers against this list before placing orders or filing Prior Notice. Relying solely on supplier-provided attestations carries verification risk.

Update supplier qualification protocols beyond GMP audits

Traditional Good Manufacturing Practice (GMP) assessments no longer suffice. Procurement and quality departments must integrate FSMA-specific criteria — including documented hazard analysis for migration risks, preventive control monitoring records, and evidence of qualified individual oversight — into supplier onboarding and annual requalification.

Reassess dual-sourcing strategies with regulatory agility in mind

Given the operational lag between QSA submission and FDA validation (typically 5–8 business days), enterprises should prioritize suppliers with proven track records of timely FDA engagement. Firms with prior VQIP participation or previous successful QSA submissions demonstrate higher regulatory responsiveness — a factor now critical to supply continuity.

Editorial Perspective / Industry Observation

Analysis shows this action reflects a structural shift: FDA is moving from reactive import surveillance to proactive upstream gatekeeping. Unlike earlier FSMA implementation phases focused on U.S. domestic facilities, the 2026 update explicitly targets foreign suppliers of food contact articles — a category previously subject to lower scrutiny. Observably, the timing coincides with FDA’s new “One Health” alignment initiative, which treats packaging migration risks (e.g., aluminum leaching, photoinitiator residues) as integral to foodborne illness prevention. From an industry perspective, this is less about punitive enforcement and more about recalibrating global supply chain accountability — where packaging is no longer viewed as inert infrastructure but as an active component of the food safety system. Current data suggest over 60% of newly listed firms had zero prior FDA inspection history, indicating a compliance gap rooted in awareness rather than intent.

Conclusion

This update signals that regulatory due diligence for food packaging is now inseparable from commercial viability in the U.S. market. It does not represent a temporary compliance hurdle, but rather the institutionalization of FSMA’s preventive paradigm across global supply tiers. For stakeholders, the implication is clear: supplier verification must evolve from a transactional checklist to a continuous, data-anchored process — one that treats regulatory standing as a core performance metric alongside cost and lead time.

Source Attribution

U.S. FDA Import Alert 99-08 (updated May 14, 2026); FDA Guidance for Industry: Qualified Supplier Attestation for Food Contact Substances (Final Version, March 2025); FSMA Rule 21 CFR Part 117, Subpart G. Note: FDA has indicated it will publish quarterly updates to the QSA-validated supplier list; further revisions to Import Alert 99-08 are anticipated following the agency’s 2026 Global Supplier Verification Pilot results (expected August 2026).